Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG0706

Il15ra Knockout RAW 264.7 Cell Line

  • Product Type:

    Genome-edited Cells

  • Tissue Source:

    Ascites

  • Disease:

    Leukemia

  • Gene Species:

    Mus musculus (Mouse)

The Il15ra Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited knockout cell line from mouse RAW 264.7 macrophages, with targeted disruption of Il15ra. This model abolishes IL-15RA function, blocking high-affinity IL-15 binding and trans-presentation that normally activates JAK/STAT5 and PI3K/AKT pathways, impairing survival signals via Bcl-2, Myc, and cyclin D1. It serves as a crucial tool for studying IL-15 signaling in macrophage inflammatory responses, tumor microenvironments, and autoimmune diseases, supporting assays such as phospho-STAT5 western blotting, flow cytometry, ELISA, and co-culture systems for drug screening and mechanistic insights.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    RAW 264.7

    Age

    Adult

    Sex of Donor

    Male

    Gene Name

    Il15ra

    Gene Species

    Mus musculus (Mouse)

    Gene Identifier

    NCBI Gene ID 16169

  • Culture Conditions

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

    Pathogens

    Cells tested negative for HIV-1, HBV, and HCV.

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The Il15ra Knockout RAW 264.7 Cell Line is a CRISPR/Cas9-edited knockout cell line manufactured from the mouse macrophage cell line RAW 264.7, featuring targeted disruption of the Il15ra gene. This loss-of-function model enables precise dissection of IL-15 receptor alpha-dependent signaling in a well-characterized macrophage background. The knockout eliminates functional IL-15RA expression, providing a defined system for studying IL-15-mediated responses without the need for pharmacological inhibitors or RNA interference.

The host cell line, RAW 264.7, is an extensively used murine macrophage model derived from a BALB/c mouse and transformed with Abelson murine leukemia virus. These cells exhibit key macrophage functions including phagocytosis, cytokine production, and antigen presentation, making them suitable for investigating innate immunity, inflammation, and host-pathogen interactions. Their robust growth and well-documented signaling pathways further enhance their utility for genetic manipulation studies.

The Il15ra gene encodes the high-affinity alpha subunit of the IL-15 receptor, which binds IL-15 and presents it in trans to cells expressing the IL-2RB/IL-2RG heterodimer, initiating signaling cascades. Upon IL-15 engagement, JAK1 and JAK3 phosphorylate STAT5, which translocates to the nucleus to drive expression of Bcl-2, Bcl-xL, Myc, and cyclin D1. Additionally, IL-15RA trans-presentation activates PI3K-AKT and MAPK pathways, promoting cell survival, proliferation, and immune activation. Upstream regulators include interferon-gamma and NF-kB, while downstream effectors such as STAT5 and Bcl-2 mediate anti-apoptotic and proliferative responses.

In RAW 264.7 macrophages, ablation of Il15ra disrupts IL-15 responsiveness, impairing the JAK/STAT, PI3K/AKT, and MAPK signaling cascades that underpin macrophage effector functions. This knockout cell line is a valuable tool for dissecting the role of IL-15 trans-presentation in macrophage biology, including its contributions to inflammatory cytokine secretion, phagocytic activity, and crosstalk with T cells and NK cells within immune microenvironments.

Researchers can employ this knockout model in diverse settings, such as quantifying phospho-STAT5 by western blotting, measuring proliferation and survival via flow cytometry, and assessing Bcl-2 and Myc transcription by RT-qPCR. Additional assays include ELISA-based cytokine profiling, phagocytosis assays, and co-culture systems. This cell line is ideally suited for studying IL-15 signaling in inflammation, tumor microenvironments, and autoimmune diseases, as well as for drug screening targeting the IL-15 pathway. For further details, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)